Leading animal healthcare company Hester Biosciences Limited announced the appointment of Dr. Ram Prakash, SVP – Sales & Marketing, as Chief Operating Officer of the company, with effect from March 1, 2024. According to the company’s exchange filing, “Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) read…
Tag: Hester Biosciences
Hester Biosciences Ltd appoints Anil Jain and Jatin Trivedi to its Board
by
•Hester Biosciences Limited, a leading animal healthcare company, announced the appointment of Anil Jain and Jatin Trivedi to its Board of Directors. Anil Jain is a distinguished veteran in the chemical industry, with an impressive track record of over three decades in manufacturing and exporting specialty fine chemicals. As the founder, CEO, and Managing Director…
Hester Biosciences re-appoints Rajiv Gandhi as MD & CEO
by
•Animal healthcare company Hester Biosciences Limited announced the re-appointment of Rajiv Gandhi as Managing Director and Chief Executive Officer of the company, with effect from April 1, 2023. According to the company’s exchange filing, “we would like to inform you that Board of Directors by circulation of resolution, and on the recommendations of the Nomination…
Hester Biosciences appoints Priya Gandhi and Ameet Desai to its Board
by
•Animal healthcare company Hester Biosciences Limited announced the appointments of Priya Gandhi and Ameet Desai as an Additional Directors to its Board. Priya Gandhi joined Hester Biosciences in the year 2016 and has worked since then from being an officer to a Deputy Director, before being inducted in the board. She is currently part of…
IIT Guwahati and Hester Biosciences join hands to develop vaccine against COVID-19
by
•Hester Biosciences Limited, a Gujarat-based pharmaceutical company has announced that it has entered into a collaboration with Indian Institute of Technology Guwahati to work on the vaccine development against COVID-19. The agreement between the two parties was signed on 15th April 2020. “The vaccine will be based on recombinant avian paramyxovirus based vector platform. The…